Does Insulin Lower Blood Glucose? How It Works

Insulin lowers blood glucose by enabling cells to absorb and use glucose from the bloodstream, making it essential for managing both type 1 and type 2 diabetes. Produced by the pancreas, insulin acts on muscle, fat and liver cells to reduce circulating glucose levels through several coordinated mechanisms. This article explains how insulin works in the body, the types available on the NHS, factors that can reduce its effectiveness, the risk of hypoglycaemia, and how to monitor whether your dose is keeping blood glucose within a safe range.

How does insulin lower blood glucose in the body?

Insulin lowers blood glucose by binding to receptors on muscle, fat and liver cells, triggering GLUT4 transporters to move glucose into cells and suppressing hepatic glucose production.

Yes, insulin lowers blood glucose by enabling cells throughout the body to absorb glucose from the bloodstream and use it for energy. Insulin is a hormone produced by the beta cells of the pancreas.^[12] When blood glucose rises after a meal, the pancreas releases insulin into the bloodstream, where it binds to insulin receptors on the surface of muscle, fat and liver cells. This binding triggers a series of molecular signals that cause glucose transporter proteins (particularly GLUT4) to move to the cell surface, allowing glucose to enter the cell.

In the liver, insulin has an additional role: it suppresses both the production of new glucose (gluconeogenesis) and the breakdown of stored glycogen (glycogenolysis), reducing the amount of glucose the liver releases into the bloodstream. In fat tissue, insulin suppresses lipolysis (the breakdown of stored fat into fatty acids and glycerol). The glycerol component can contribute to gluconeogenesis, but fatty acids themselves are not converted to glucose in humans. Together, these actions reduce the concentration of glucose circulating in the blood.

In people with type 1 diabetes, the pancreas produces little or no insulin, so injected or infused insulin is essential for survival. In type 2 diabetes, the body either does not produce enough insulin or does not respond to it effectively (insulin resistance), and injected insulin may be needed when other treatments are insufficient. Understanding this mechanism helps explain why the timing, dose and type of insulin all matter for achieving stable blood glucose levels.

What types of insulin are available on the NHS and how do they differ?

NHS insulins range from rapid-acting analogues (onset 10 to 20 minutes) to long-acting basal insulins lasting 24 hours or more, with choice guided by diabetes type, lifestyle and NICE guidance.

Several distinct types of insulin are available on the NHS, and they differ primarily in how quickly they start to act and how long their effect lasts. The main categories are:

• Rapid-acting analogues (for example, insulin aspart, insulin lispro and insulin glulisine): these begin working within 10 to 20 minutes of injection and are typically taken just before or with meals to manage the rise in blood glucose after eating.^[1][15]

• Ultra-rapid-acting analogues (for example, faster-acting insulin aspart): these have an even quicker onset than standard rapid-acting analogues and are used in some insulin pump regimens and multiple daily injection regimens.

• Short-acting (soluble) insulins (for example, Actrapid): these take around 30 minutes to start working and are usually injected 15 to 30 minutes before a meal.

• Intermediate-acting insulins (for example, isophane insulin, also known as NPH): these have a slower onset and a longer duration, often used once or twice daily to provide background glucose control.

• Long-acting analogues (for example, insulin glargine, insulin detemir and insulin degludec): these provide a relatively steady level of insulin over 24 hours or longer, with no pronounced peak, making them suitable as basal (background) insulin. Concentrated formulations of some basal insulins (for example, insulin glargine 300 units/mL and insulin degludec 200 units/mL) are also available on the NHS and may be appropriate for people with higher insulin requirements.^[3][11]

• Mixed insulins: pre-mixed combinations of rapid or short-acting and intermediate-acting insulin, which can simplify regimens for some people.

The choice of insulin regimen depends on the type of diabetes, lifestyle, blood glucose patterns and individual clinical need. NICE guidance (NG17 for type 1 diabetes and NG28 for type 2 diabetes) supports a range of regimens, and decisions are made in partnership between the person and their diabetes care team.^[6][8] Switching between insulin types should always be done under medical supervision, as doses may need adjustment.

What can stop insulin from working properly?

Insulin effectiveness is reduced by improper storage, injecting into lipohypertrophic tissue, illness, physical inactivity and medicines such as corticosteroids or thiazide diuretics.

Several factors can reduce the effectiveness of insulin and lead to higher than expected blood glucose levels. Understanding these helps people using insulin to troubleshoot problems and seek appropriate support.

Storage and handling issues are a common cause. Insulin that has been exposed to excessive heat, frozen, or used beyond its expiry date may lose potency. Storage requirements vary between products: most insulins should be kept in a refrigerator (2 to 8 degrees Celsius) before opening. Once in use, the permitted storage temperature and duration differ by product and are set out in each insulin's patient information leaflet (PIL) and summary of product characteristics (SmPC). Always follow the instructions for your specific insulin rather than applying a general rule.

Injection technique also matters. Injecting into areas of lipohypertrophy (lumpy, hardened tissue caused by repeated injections in the same spot) significantly impairs absorption. Rotating injection sites within the recommended areas (abdomen, thighs, upper arms and buttocks) helps maintain consistent absorption.

Illness and infection cause the body to release stress hormones such as cortisol and adrenaline, which raise blood glucose and increase insulin resistance. During illness, insulin requirements often increase even if food intake falls.

Sick-day guidance and DKA red flags: People with type 1 diabetes (and those with type 2 diabetes on insulin) should follow sick-day rules during any illness. Key principles include:

• Never stop basal insulin, even if you cannot eat.

• Check blood glucose more frequently than usual.

• If you have type 1 diabetes or are at risk of diabetic ketoacidosis (DKA), check blood ketones if your glucose is persistently high or you feel unwell.

• Maintain fluid intake and, where possible, carbohydrate intake.

• Contact your diabetes team or NHS 111 if glucose remains persistently above 13 to 15 mmol/L with positive ketones, or if you are vomiting, have abdominal pain, are breathing rapidly or feel drowsy.

• Call 999 or go to the nearest emergency department immediately if symptoms are severe or you are unable to manage at home.

If you are pregnant and using insulin, contact your antenatal diabetes team promptly if you are unwell, as insulin requirements can change rapidly and the risks of high glucose and DKA are greater during pregnancy.

Other factors that can impair insulin action include:

• Physical inactivity

• Significant weight gain

• Certain medicines (for example, corticosteroids, some antipsychotics and thiazide diuretics)

• Hormonal changes, including those related to the menstrual cycle or pregnancy

If blood glucose remains persistently high despite correct technique and storage, a review with a GP or diabetes nurse is recommended.

Can your blood glucose drop too low when using insulin?

Yes, insulin can cause hypoglycaemia (blood glucose below 4 mmol/L), treated with 15 g of fast-acting carbohydrate; severe episodes require glucagon and an emergency 999 call.

Blood glucose can drop too low when using insulin, a condition known as hypoglycaemia (commonly called a "hypo"), and this is one of the most important safety considerations for anyone on insulin therapy. Hypoglycaemia is generally defined as a blood glucose level below 4 mmol/L, though symptoms can vary between individuals.^[2][13]

Common symptoms of hypoglycaemia include shakiness, sweating, palpitations, hunger, dizziness, difficulty concentrating and irritability. If blood glucose falls further, more serious symptoms such as confusion, slurred speech or loss of consciousness can occur.

Mild to moderate hypoglycaemia is treated with fast-acting carbohydrates, such as glucose tablets, a small glass of fruit juice or a sugary drink, followed by a longer-acting carbohydrate snack once blood glucose has recovered. NHS guidance supports the "15 to 15" approach as a general guide: take 15 grams of fast-acting carbohydrate, wait 15 minutes, and recheck blood glucose.^[2][13]

For severe hypoglycaemia where the person is unconscious or unable to swallow safely: do not give anything by mouth. If a carer has been trained and prescribed glucagon (available as a nasal powder or injectable preparation), this can be administered.^[14] Place the person in the recovery position and call 999 immediately. Emergency services should also be called if the person does not recover promptly after glucagon.

Hypoglycaemia can be triggered by:

• Taking too much insulin

• Delaying or skipping meals

• Unplanned or unusually intense physical activity

• Alcohol consumption, particularly without food

• Interactions with certain medicines

People using insulin should always carry fast-acting glucose with them and ensure that those around them know how to recognise and respond to a hypo. Recurrent hypoglycaemia should be discussed with a GP or diabetes specialist, as the insulin regimen may need adjustment. Suspected adverse effects from insulin can be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

How do you know if your insulin dose is keeping your levels in range?

Blood glucose is assessed through self-monitoring, real-time CGM (recommended by NICE for all adults with type 1 diabetes) and HbA1c measured every 3 to 6 months.

Regular blood glucose monitoring is the primary way to assess whether an insulin dose is keeping levels within a safe and agreed target range.

Self-monitoring of blood glucose (SMBG): NICE guidance (NG17) recommends that people with type 1 diabetes who are not using a continuous glucose monitor test their blood glucose at least four times daily, including before meals and before bed, though many people test more frequently.^[7] For people with type 2 diabetes on insulin, the frequency of testing is guided by individual clinical need and agreed with the care team.

Continuous glucose monitoring (CGM): NICE now recommends that real-time CGM is offered to all adults with type 1 diabetes.^[10] CGM devices measure glucose levels in the fluid under the skin every few minutes, providing a more complete picture of glucose patterns throughout the day and night, including trends and time spent in range. Access follows national NICE guidance and local Integrated Care Board (ICB) commissioning pathways. Some people with type 2 diabetes on insulin may also be eligible; eligibility is determined by the care team. People using CGM should follow the monitoring guidance provided with their device and by their diabetes team.

HbA1c: Glycated haemoglobin (HbA1c) is a blood test measured every 3 to 6 months in clinical practice. It reflects average blood glucose over approximately 2 to 3 months and is a key indicator of longer-term glucose control.^[12] Targets are individualised: for many adults with type 1 diabetes, NICE suggests aiming for an HbA1c of 48 mmol/mol (6.5%) or below, but higher targets may be agreed for people at significant risk of hypoglycaemia or with relevant comorbidities. For people with type 2 diabetes on insulin, targets are set in discussion with the care team, taking into account age, hypoglycaemia risk and other health conditions (NICE NG28).

Target blood glucose ranges also vary by individual. NICE guidance for adults with type 1 diabetes generally suggests aiming for 5 to 7 mmol/L on waking and 4 to 7 mmol/L before meals, but agreed targets may differ.^[5][6]

If monitoring suggests that blood glucose is consistently outside the agreed range, a review with a GP, diabetes nurse or specialist is the appropriate next step to adjust the regimen safely.

Scientific References

1. About rapid-acting insulin.
2. Low blood sugar (hypoglycaemia).
3. How and when to take long-acting insulin.
4. Insulin for type 2 diabetes.
5. Living with type 1 diabetes.
6. Type 1 diabetes in adults: diagnosis and management (NG17).
7. Type 1 diabetes in adults: diagnosis and management (NG17) – Recommendations.
8. Type 2 diabetes in adults: management (NG28) – Insulin-based treatments.
9. Type 2 diabetes in adults: management (NG28) – Blood glucose management.
10. Continuous glucose monitoring – Quality statement 2 (QS208).
11. Type 2 diabetes mellitus in adults: high-strength insulin (ESNM65).
12. Insulin – Treatment summaries.
13. Hypoglycaemia – Treatment summaries.
14. Glucagon.
15. Trurapi 100 units/ml solution for injection in pre-filled pen (insulin aspart).
16. Apidra (insulin glulisine) – Scientific discussion.
17. Insulin degludec (Tresiba): available in additional higher strength.
18. Are Fatty Acids Gluconeogenic Precursors? Green MH. Journal of Nutrition. 2020..
19. Canonical and Alternative Pathways (Insulin and Exercise) of GLUT4 Synthesis, Signaling, Intracellular Clustering, and Recruitment to the Plasma Membrane. International Journal of Molecular Sciences. 2025..

Frequently Asked Questions